Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Evaluation of Postoperative Outcomes and Mortality in Laparoscopic and Robotic Distal Pancreatectomy

NCT07338409 · Jessa Hospital · Updated 13 Jan 2026

What is being tested
Not stated
For
Distal Pancreatectomy (DP)
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 126 people. The full rules are on the registry page.
Where
Belgium
When
Starts or started 4 March 2025, ends 5 June 2025. Registered 13 Jan 2026.
Results
None posted yet.

In the researchers' words

Minimally invasive distal pancreatectomy can be performed using either a laparoscopic or robotic approach. These minimally invasive techniques are becoming increasingly common in the surgical treatment of both benign and malignant pancreatic lesions. They offer several advantages over traditional open surgery, such as less postoperative pain, better cosmetic results, faster recovery, less blood loss during surgery, and lower healthcare costs. However, despite these advantages, evidence comparing postoperative outcomes, particularly complications, between laparoscopic and robotic distal pancreatectomy remains limited. Previous studies suggest that robotic surgery may offer technical benefits, such as greater accuracy and precision, which could potentially result in fewer complications. However, the available literature is diverse and often based on small cohorts.
ClinicalTrials.gov, NCT07338409

Sites

  • Jessa HospitalHasselt, Belgium